GENinCode (LON:GENI) Issues Earnings Results

GENinCode (LON:GENI) released its earnings results on Tuesday. The company reported GBX (0.38) earnings per share for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 409.40% and a negative net margin of 185.47%.

GENinCode Price Performance

Shares of GENinCode stock traded up GBX 0.03 during trading on Wednesday, hitting GBX 0.72. The stock had a trading volume of 3,739,150 shares, compared to its average volume of 5,139,059. The business has a fifty day moving average of GBX 0.88 and a two-hundred day moving average of GBX 0.99. GENinCode has a fifty-two week low of GBX 0.64 and a fifty-two week high of GBX 4.90. The firm has a market cap of £5.46 million, a P/E ratio of -0.35 and a beta of 0.59. The company has a debt-to-equity ratio of 117.74, a current ratio of 0.93 and a quick ratio of 15.88.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.